News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Human Metabolome Technologies Joins National Cancer Institute's OSTR Subsidy Program


7/7/2014 10:05:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, has been recognized by the National Cancer Center’s Office of Science and Technology Resources (OSTR) as a preferred vendor of metabolomic services. Under this program, new technology costs are subsidized by the OSTR in an effort to advance cancer research for NCI's Center for Cancer Research (CCR) investigators.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES